Uluhlu lweMida ye-SAD
Zininzi iintlobo ezahlukeneyo zamachiza ezinqunyelwe ukuphatha ingxaki yokuxhalabisa abantu (SAD) . Ngamnye unamathuba ayo kunye neentsikelelo kuye kuxhomekeke kwimeko ethile.
Ukuhlaziywa kwe-Meta yokusebenza kwamachiza kunyango lwe-SAD sele kufumaneke ubungakanani obuncinane bokusebenza kwolu hlobo lwenyango-nazo zonke iindidi ezilandelayo zonyango ezibonisa ukuphucula.
Oku kuthetha ukuba iintlobo ezahlukahlukeneyo zonyango zinokukunceda ekuphuculeni iimpawu zengxaki yokuxhalaba kwentlalo, kwaye loo nto inokuba yindlela efanelekileyo yokonyango kuwe.
Benzodiazepines
I-Benzodiazepines iyanciphisa iimpawu zokuxhalabisa ngokunciphisa inkqubo yesantya . I-Benzodiazepines inokubangela ukuba i-sedation neempembelelo zecala, kwaye ibe nekhono lokwenza umkhwa, kwaye ngoko ayisetyenziswanga njengowokuqala wonyango lwe-SAD.
- Ativan (lorazepam)
- Valium (diazepam)
- Xanax (alprazolam)
- Klonopin (clonazepam)
Beta Blockers
Iibet blockers zivame ukuthathwa phambi komcimbi wokuxhalabisa, njengentsebenzo yokunciphisa iimpawu zokuxhalabisa. Iibet blockers zixhamla kwiimeko ezifuna ukuqina kwengqondo, kuba abanalo miphumo emibi ekunokwenzeni ingqiqo njengokwenene benzodiazepines.
- Inderal (propranolol)
- Tenormin (i-atenolol)
I-Monoamine Oxidase Inhibitors (MAOIs)
I-MAOIs yayisandul 'ingqalelo njengonyango olusebenzayo kwiinkathazo zentlalo; nangona kunjalo la mayeza ayenomngcipheko weempembelelo ezibi kakhulu ukuba izikhokelo zokutya kunye neyeza zilandelwa.
Namhlanje, ii-MAOIs aziqhelekanga zisetyenziswe kunyango lwe-SAD, ngaphandle kokuba kukho isizathu sokukholelwa ukuba baya kuba luncedo kunamanye amayeza (njengembali yentsapho yeziphumo ezilungileyo).
Enyanisweni, ukuba uhlalutyo lwe-meta-2014 lufumene ukuba i-phenelzine (igama legama elithi Nardil) yindlela efanelekileyo kakhulu ye-pharmacotherapy yokukhathazeka kwintlalo yoluntu, ngoko ungabali ii-MAOIs ngaphandle kwendlela yokwenza unyango onokumiselwa ngugqirha wakho.
- Nardil (phenelzine)
- Parnate (tranylcypromine)
- Marplan (isocarboxazid)
I-Serotonin Reuptake Inhibitors (i-SSRIs)
I-SSRI iyona mgca wokuqala unyango lwe-SAD ngenxa yemiphumo engacatshangelwayo kunye nokukhululeka kolawulo. Ngenxa yobuchule bokuthintela, i-SSR kufuneka ihlale ifakwe xa ipheliswa unyango.
Ukuhlaziywa kwemeta-meta ka-2014 kufumene i-paroxetine (igama lophawu lwegama elithi Paxil) ukuba libe yindlela yesibini efanelekileyo kakhulu yokwelapha unyango lwengxaki yokuxhalabisa abantu.
- I-Paxil CR (i-paroxetine)
- Luvox CR (i-fluvoxamine)
- Zoloft (sertraline)
- Lexapro (escitalopram)
- Celexa (citalopram)
- Prozac (i-fluoxetine)
I-Serotonin Norepinephrine Reuptake Inhibitors (i-SNRIs)
I-SNRIs yinkalo yezinto ezixhatshazwayo ezisetyenziselwa unyango lwexhala elisebenza kwi-neurotransmitters serotonin kunye ne-norepinephrine. I-Venlafaxine ikhutshwe ngokukhululeka (igama lophawu lwegama elithi Exexor) lifunyenwe luhlobo lwesithathu oluchanekileyo lwemishishini ye-SAD kule ngxelo-meta-2014.
- I-Exexor XR (venlafaxine)
- Cymbalta
Ezinye iinkxalabo
Ukuba awuqinisekanga ngamanyathelo akho unyango, xela ugqirha malunga nokusetyenziswa kwamachiza kwimeko ethile.
Umthombo:
Bezchlibnyk-Butler KZ, Jeffries, JJ, eds. Incwadi YesiKlinikhi yee-Psychotropic Drugs . I-Toronto, Canada: Hogrefe & Huber; 2003.
Davis ML, Smits JA, Hofmann SG. Ukuhlaziywa kokusebenza kwe-pharmotherapy kwimeko yokuxhalabisa abantu: i-meta-analysis. Iingcamango zengcali kwi-Pharmacotherapy . 2014; 15 (16): 2281-2291. I-doi: 10.1517 / 14656566.2014.955472.
Mayo-Wilson E, Dias S, Mavranezouli I, et al. Ukungenelela kweengqondo kunye ne-pharmacological kwintlupheko yokukhathazeka kwentlalo kubantu abadala: ukuphononongwa ngokuchanekileyo kunye nohlalutyo lwe-meta-analysis. I-Lancet Psychiatry . 2014; 1 (5): 368-376. i-doi: 10.1016 / S2215-0366 (14) 70329-3.